Skip to main content
For research use only — not for human consumption
Acetyl Pentapeptide-35 original Regena research vial

Cosmetic · N-acetylated synthetic pentapeptide; sequence requires verification

Acetyl Pentapeptide-35

Also known as —

A five-residue acetylated peptide designation for identity-led research; its receptor pharmacology remains unresolved.

Length
5 amino acids
Half-life
Not well characterised
Mechanism
No specific receptor or molecular mechanism can be stated confidently from independently verified compound-specific evidence. N-terminal acetylation is a structural feature, not evidence of a particular biological activity.
Studied in
Sequence-confirmed material can be examined in biochemical stability and exploratory cell-based assays, but a validated compound-specific laboratory model is not confidently established.

About Acetyl Pentapeptide-35

Acetyl Pentapeptide-35 is named as an acetylated peptide containing five amino-acid residues. Neither the residue order nor the C-terminal chemistry can be reconstructed from that name alone. Acetylation typically caps the N-terminal amino group and changes its charge, but its effects on stability depend on the complete structure and assay environment. For research use only, a supplier should provide sequence-level documentation rather than rely solely on the cosmetic-ingredient designation.

A traceable discovery account, biological sequence origin and independently established receptor target cannot be supplied confidently for this entry. Those gaps should remain explicit instead of being filled with mechanisms borrowed from similarly named peptides. Initial laboratory work can establish purity, solution behaviour and persistence in assay media. Subsequent cellular studies should use predefined endpoints and orthogonal controls, separating genuine signalling responses from precipitation, assay interference or changes in cell viability.

Laboratory notes

  • Request sequence, stereochemistry, terminal chemistry and a batch-specific identity spectrum before selecting mechanistic assays.
  • Measure peptide persistence in the chosen medium by a suitable analytical method rather than assuming that acetylation prevents degradation.
  • Include cell-free interference controls when using fluorescence, luminescence or colourimetric endpoint assays.

Storage and reconstitution basics: storage guide.

Questions about Acetyl Pentapeptide-35

Does acetylation guarantee resistance to proteases?

No. It may affect recognition by some enzymes, but internal cleavage and other degradation processes depend on the sequence and experimental conditions.

Is a biological source sequence established?

A source sequence cannot be identified confidently here. Claims that it mimics a natural protein fragment require a traceable sequence comparison and supporting source.

What is needed to report a meaningful stability value?

The exact peptide identity, medium, temperature, sampling schedule and analytical method must be specified. Chemical persistence in buffer is not interchangeable with stability in a biological matrix.

Is Acetyl Pentapeptide-35 for human use?

No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.

Related research peptides

All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.